Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Motoki Eguchi"'
Publikováno v:
Biomedicines, Vol 8, Iss 8, p 245 (2020)
FLT3-ITD and FLT3-TKD mutations were observed in approximately 20 and 10% of acute myeloid leukemia (AML) cases, respectively. FLT3 inhibitors such as midostaurin, gilteritinib and quizartinib show excellent response rates in patients with FLT3-mutat
Externí odkaz:
https://doaj.org/article/965ac36f555245f6a1a00ff3c0a91a2e
Autor:
Keisuke Oka, Takeshi Kanematsu, Hitoshi Kiyoi, Motoki Eguchi, Yoshihiko Hoshino, Nobuyuki Tetsuka, Tetsuya Yagi, Yoshitaka Sato, Hanako Fukano, Hiroshi Morioka, Mitsutaka Iguchi
Publikováno v:
Internal Medicine. 60:3041-3045
We herein report a 59-year-old woman with a 2-year history of chronic bursitis of the hand who took 50 mg/day prednisolone for several autoimmune diseases. Mycobacteroides abscessus subsp. massiliense was isolated from the abscess and blood culture.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fbf6689058ce3b4b9e60d15e1555cbc
https://doi.org/10.2169/internalmedicine.6189-20
https://doi.org/10.2169/internalmedicine.6189-20
Autor:
Motohito Okabe, Motoki Eguchi, Kenichiro Takeda, Kohei Ishigiwa, Koichi Miyamura, Tatsunori Goto, Yuka Kawaguchi, Yukiyasu Ozawa, Takanobu Morishita, Rena Matsumoto, Tomoe Ichiki, Yosuke Domon, Marie Ohbiki, Tomoki Naito
Publikováno v:
Bone Marrow Transplantation. 56:1732-1736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4553d3668841f277286f172127293211
https://doi.org/10.1038/s41409-021-01241-w
https://doi.org/10.1038/s41409-021-01241-w
Autor:
Naoko Hosono, Takahiro Yamauchi, Sunggi Chi, Seiichiro Katagiri, Akihiko Gotoh, Motoki Eguchi, Takanobu Morishita, Reiki Ogasawara, Takeshi Kondo, Masamitsu Yanada, Kazuhito Yamamoto, Tsutomu Kobayashi, Junya Kuroda, Kensuke Usuki, Yoshikazu Utsu, Nobuyuki Aotsuka, Makoto Yoshimitsu, Kenji Ishitsuka, Takaaki Ono, Yosuke Minami
Publikováno v:
Annals of Oncology. 33:S469
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f77a2cfdf0895745a08fc16964ad63c
https://doi.org/10.1016/j.annonc.2022.05.023
https://doi.org/10.1016/j.annonc.2022.05.023
Publikováno v:
Biomedicines, Vol 8, Iss 245, p 245 (2020)
Biomedicines
Biomedicines
FLT3-ITD and FLT3-TKD mutations were observed in approximately 20 and 10% of acute myeloid leukemia (AML) cases, respectively. FLT3 inhibitors such as midostaurin, gilteritinib and quizartinib show excellent response rates in patients with FLT3-mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234766ed26d25a48853c0af5c68a565f
https://www.mdpi.com/2227-9059/8/8/245
https://www.mdpi.com/2227-9059/8/8/245
Autor:
Nobuyuki Aotsuka, Akihiko Gotoh, Seiichiro Katagiri, Yosuke Minami, Yukinori Nakamura, Naoko Hosono, Junichiro Yuda, Takaaki Ono, Makoto Yoshimitsu, Takeshi Kondo, Takanobu Morishita, Kenji Ishitsuka, Satoshi Iyama, Tsutomu Kobayashi, Nobuhiko Yamauchi, Naoto Takahashi, Junya Kuroda, Hirohiko Shibayama, Motoki Eguchi, Suguru Fukuhara, Koji Izutsu, Takahiro Yamauchi, Masamitsu Yanada, Makoto Nakamura, Reiki Ogasawara, Yoshikazu Utsu, Kensuke Usuki, Kentaro Fukushima, Kazuhito Yamamoto, SungGi Chi
Publikováno v:
Blood. 138:4457-4457
Background: Recently, whole exome sequencing has been used for the next-generation sequencing of acute myeloid leukemia (AML), and certain gene mutations have been identified in patients with AML. The treatment strategies for leukemia have undergone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b84370309292c25b95a1ae75dd528334
https://doi.org/10.1182/blood-2021-149960
https://doi.org/10.1182/blood-2021-149960
Autor:
Naoko Hosono, Takaaki Ono, Takeshi Kondo, Tsutomu Kobayashi, Akihiko Gotoh, Kentaro Fukushima, Kensuke Usuki, SungGi Chi, Kenji Ishitsuka, Seiichiro Katagiri, Kazuhito Yamamoto, Yukinori Nakamura, Kaoru Yamamoto, Makoto Yoshimitsu, Takahiro Yamauchi, Suguru Fukuhara, Hiroto Horiguchi, Nobuhiko Yamauchi, Yoshikazu Utsu, Hirohiko Shibayama, Koji Izutsu, Junya Kuroda, Makoto Nakamura, Junichiro Yuda, Takanobu Morishita, Yasuyuki Nagata, Reiki Ogasawara, Nobuyuki Aotsuka, Yoshimasa Kamoda, Motoki Eguchi, Yosuke Minami, Naoto Takahashi, Kensuke Kojima, Masamitsu Yanada, Satoshi Iyama, Naohito Fujishima
Publikováno v:
Blood. 138:4460-4460
Background and Methods: NPM1 mutation and KMT2A(MLL)-rearrangement/amplification are present in approximately 27% and 8.5% patients with acute myeloid leukemia (AML), respectively (data from cBioPortal). Although they have different clinical features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80044e595207794651d49e8234d4e4b
https://doi.org/10.1182/blood-2021-149425
https://doi.org/10.1182/blood-2021-149425
Autor:
Daigo Akahane, Yoshikazu Utsu, Yukinori Nakamura, Kensuke Usuki, Makoto Nakamura, Makoto Yoshimitsu, Kenji Ishitsuka, Junya Kuroda, SungGi Chi, Koji Izutsu, Reiki Ogasawara, Masamitsu Yanada, Nobuyuki Aotsuka, Seiichiro Katagiri, Yosuke Minami, Takahiro Yamauchi, Hirohiko Shibayama, Naoto Takahashi, Akihiko Gotoh, Tsutomu Kobayashi, Nobuhiko Yamauchi, Takanobu Morishita, Motoki Eguchi, Kentaro Fukushima, Naoko Hosono, Takaaki Ono, Takeshi Kondo, Satoshi Iyama, Junichiro Yuda, Kazuhito Yamamoto
Publikováno v:
Blood. 138:4464-4464
Background and Methods: Acute myeloid leukemia (AML) bearing the RUNX1-RUNX1T1 fusion gene is known to be one of the core-binding factor AML (CBF-AML) which exerts relatively good prognosis. The RUNX1-RUNX1T1 fusion gene are present in approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36faff25af16cd14b5cee597f4ace9fd
https://doi.org/10.1182/blood-2021-148492
https://doi.org/10.1182/blood-2021-148492
Autor:
Kenji Ishitsuka, Motoki Eguchi, Yosuke Minami, Reiki Ogasawara, Takahiro Yamauchi, Hirohiko Shibayama, Makoto Yoshimitsu, SungGi Chi, Satoshi Uchiyama, Naoto Takahashi, Masamitsu Yanada, Nobuyuki Aotsuka, Junichiro Yuda, Nobuhiko Yamauchi, Satoshi Iyama, Tsutomu Kobayashi, Makoto Nakamura, Kensuke Usuki, Yukinori Nakamura, Kentaro Fukushima, Seiichiro Katagiri, Nakamura Hirotaka, Kazuhito Yamamoto, Takanobu Morishita, Junya Kuroda, Akihiko Gotoh, Naoko Hosono, Takaaki Ono, Takeshi Kondo, Suguru Fukuhara, Koji Izutsu
Publikováno v:
Blood. 138:4447-4447
Background: Isocitrate dehydrogenase (IDH)-1 and -2 are TCA cycle-involved enzymes which convert isocitrate to alpha-ketoglutarate. Mutations that alter the enzymatic activity causes accumulation of a mal-metabolite D-2-hydroxyglutarate, which result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10265b5c8d535bb590ce424e70f9acf4
https://doi.org/10.1182/blood-2021-149801
https://doi.org/10.1182/blood-2021-149801
Autor:
Kentaro Fukushima, Yukinori Nakamura, Satoshi Iyama, Naoko Hosono, Takaaki Ono, Akihiko Gotoh, Kazuhito Yamamoto, Masamitsu Yanada, Takanobu Morishita, Junya Kuroda, Makoto Yoshimitsu, Suguru Fukuhara, Koji Izutsu, Nobuhiko Yamauchi, Takeshi Kondo, Kensuke Usuki, SungGi Chi, Reiki Ogasawara, Junichiro Yuda, Takahiro Yamauchi, Tsutomu Kobayashi, Yosuke Minami, Hirohiko Shibayama, Yoshikazu Utsu, Naoto Takahashi, Makoto Nakamura, Nobuyuki Aotsuka, Seiichiro Katagiri, Yoshimasa Kamoda, Kenji Ishitsuka, Motoki Eguchi
Publikováno v:
Blood. 138:2313-2313
Background and Methods: FMS-like tyrosine kinase 3 (FLT3) internal tandem duplication (FLT3-ITD) and tyrosine kinase domain mutation (FLT3-TKD) are types of mutations present in approximately 30% of patients with acute myeloid leukemia (AML). Current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4def46c8cab17dbc46734599936f06a9
https://doi.org/10.1182/blood-2021-146796
https://doi.org/10.1182/blood-2021-146796